Faith E. Davies is Director of the Center for Blood Cancers, Perlmutter Cancer Center and Director of the Clinical Myeloma Program, Perlmutter Cancer Center as well as Professor of Medicine at the New York University Grossman School of Medicine, New York, US.
Professor Davies earned her medical degree from the University of Wales College of Medicine and completed her general medical training and hematology specialty training in the UK. She has also held positions with the University of Arkansas for Medical Sciences, Arkansas, USA and the Institute of Cancer Research / Royal Marsden Hospital, in London, UK.
Her research focus for over two decades has been on the biology and treatment of multiple myeloma, in particular the examination of potential new drugs and new genetic technologies. She is recognized internationally for her work looking at prognostic and predictive biomarkers (e.g. genetic abnormalities, imaging and minimal residual disease) within the context of clinical trials. Professor Davies laboratory work is aimed at identifying biologically based therapeutic targets in myeloma that are amenable to small molecule interventions and translating those laboratory findings into the clinical arena with a focus on individualized treatment.
Professor Davies is an active member of the American Society of Hematology, and the American Association for Cancer Research, and enjoys participating in a number of the patient-focused organizations. She is widely published in leading peer-reviewed journals, including the New England Journal of Medicine, Lancet Oncology, Blood, Journal of Clinical Oncology, and Leukemia.
EM-94001 - Date of preparation: April 2022